Search

Lance W. Rider

Examiner (ID: 18260, Phone: (571)270-1337 , Office: P/1618 )

Most Active Art Unit
1618
Art Unit(s)
1618
Total Applications
662
Issued Applications
191
Pending Applications
1
Abandoned Applications
470

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17577036 [patent_doc_number] => 20220133891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => HEMOSTATIC MICROSPHERES [patent_app_type] => utility [patent_app_number] => 17/574229 [patent_app_country] => US [patent_app_date] => 2022-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574229 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/574229
HEMOSTATIC MICROSPHERES Jan 11, 2022 Abandoned
Array ( [id] => 17539920 [patent_doc_number] => 11305024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-19 [patent_title] => Cross-linked polymer modified nanoparticles [patent_app_type] => utility [patent_app_number] => 17/398954 [patent_app_country] => US [patent_app_date] => 2021-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 119 [patent_no_of_words] => 29281 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398954 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/398954
Cross-linked polymer modified nanoparticles Aug 9, 2021 Issued
Array ( [id] => 18517667 [patent_doc_number] => 11707538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides [patent_app_type] => utility [patent_app_number] => 17/150186 [patent_app_country] => US [patent_app_date] => 2021-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 4790 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150186 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/150186
Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides Jan 14, 2021 Issued
Array ( [id] => 16596478 [patent_doc_number] => 20210023009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 17/071418 [patent_app_country] => US [patent_app_date] => 2020-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17071418 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/071418
NANO-SIZED PARTICLES COMPRISING MULTI-HEADED AMPHIPHILES FOR TARGETED DRUG DELIVERY Oct 14, 2020 Abandoned
Array ( [id] => 16824096 [patent_doc_number] => 20210139389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [ AT 211] RADIOPHARMACEUTICALS [patent_app_type] => utility [patent_app_number] => 17/060810 [patent_app_country] => US [patent_app_date] => 2020-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8647 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060810 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/060810
Automatic process platform for the production of astatine-211 [At-211]-radiopharmaceuticals Sep 30, 2020 Issued
Array ( [id] => 16991943 [patent_doc_number] => 20210230363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => DERIVATIVES OF 1,3-PROPANEDIOL [patent_app_type] => utility [patent_app_number] => 17/014055 [patent_app_country] => US [patent_app_date] => 2020-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7041 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014055 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/014055
DERIVATIVES OF 1,3-PROPANEDIOL Sep 7, 2020 Abandoned
Array ( [id] => 17458825 [patent_doc_number] => 20220072129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => NOBLE METAL NANOPARTICLES WITH RADIAL PORES AND METHODS FOR ANTITUMOR TREATMENTS [patent_app_type] => utility [patent_app_number] => 17/012820 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6567 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012820 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/012820
Noble metal nanoparticles with radial pores Sep 3, 2020 Issued
Array ( [id] => 16236716 [patent_doc_number] => 20200253950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => Pharmaceutical Formulations Comprising CCR3 Antagonists [patent_app_type] => utility [patent_app_number] => 16/861473 [patent_app_country] => US [patent_app_date] => 2020-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8262 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861473 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/861473
Pharmaceutical formulations comprising CCR3 antagonists Apr 28, 2020 Issued
Array ( [id] => 18780181 [patent_doc_number] => 11821892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Nanobubbles [patent_app_type] => utility [patent_app_number] => 16/851130 [patent_app_country] => US [patent_app_date] => 2020-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 53 [patent_no_of_words] => 18324 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851130 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/851130
Nanobubbles Apr 16, 2020 Issued
Array ( [id] => 16221342 [patent_doc_number] => 20200246458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-06 [patent_title] => METHOD FOR TREATING CANCER BASED ON METALLOFULLERENE MONOCRYSTALLINE NANOPARTICLES THAT SPECIFICALLY DISRUPT TUMOR BLOOD VESSELS [patent_app_type] => utility [patent_app_number] => 16/837953 [patent_app_country] => US [patent_app_date] => 2020-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4573 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16837953 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/837953
METHOD FOR TREATING CANCER BASED ON METALLOFULLERENE MONOCRYSTALLINE NANOPARTICLES THAT SPECIFICALLY DISRUPT TUMOR BLOOD VESSELS Mar 31, 2020 Abandoned
Array ( [id] => 15738541 [patent_doc_number] => 20200108158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-09 [patent_title] => TARGETED CONTRAST AGENTS AND METHODS FOR TARGETING CONTRAST AGENTS [patent_app_type] => utility [patent_app_number] => 16/689718 [patent_app_country] => US [patent_app_date] => 2019-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689718 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/689718
TARGETED CONTRAST AGENTS AND METHODS FOR TARGETING CONTRAST AGENTS Nov 19, 2019 Abandoned
Array ( [id] => 15342329 [patent_doc_number] => 20200009056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => ORGANIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/576217 [patent_app_country] => US [patent_app_date] => 2019-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16576217 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/576217
ORGANIC COMPOUNDS Sep 18, 2019 Abandoned
Array ( [id] => 16009105 [patent_doc_number] => 20200179395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/574367 [patent_app_country] => US [patent_app_date] => 2019-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16574367 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/574367
PHARMACEUTICAL COMPOSITIONS Sep 17, 2019 Abandoned
Array ( [id] => 15797339 [patent_doc_number] => 20200121812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's Disease [patent_app_type] => utility [patent_app_number] => 16/555915 [patent_app_country] => US [patent_app_date] => 2019-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555915 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/555915
Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's Disease Aug 28, 2019 Abandoned
Array ( [id] => 15114231 [patent_doc_number] => 20190343748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-14 [patent_title] => VERSATILE TOPICAL DRUG DELIVERY VEHICLE AND MULTIFACTORIAL TISSUE MOISTURIZER THAT PROVIDES MUCOSAL AND SKIN BARRIER RESTORATION [patent_app_type] => utility [patent_app_number] => 16/518434 [patent_app_country] => US [patent_app_date] => 2019-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 317 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16518434 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/518434
VERSATILE TOPICAL DRUG DELIVERY VEHICLE AND MULTIFACTORIAL TISSUE MOISTURIZER THAT PROVIDES MUCOSAL AND SKIN BARRIER RESTORATION Jul 21, 2019 Abandoned
Array ( [id] => 17065913 [patent_doc_number] => 20210268128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => FLUORESCENT NANOPARTICLES AND IMAGING USES [patent_app_type] => utility [patent_app_number] => 17/253959 [patent_app_country] => US [patent_app_date] => 2019-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15141 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253959 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/253959
FLUORESCENT NANOPARTICLES AND IMAGING USES Jul 8, 2019 Abandoned
Array ( [id] => 15020979 [patent_doc_number] => 20190321494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-24 [patent_title] => POLYMALIC ACID BASED NANOCONJUGATES FOR IMAGING [patent_app_type] => utility [patent_app_number] => 16/434545 [patent_app_country] => US [patent_app_date] => 2019-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16373 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16434545 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/434545
POLYMALIC ACID BASED NANOCONJUGATES FOR IMAGING Jun 6, 2019 Abandoned
Array ( [id] => 14716035 [patent_doc_number] => 20190249081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => MORPHOLOGICALLY AND SIZE UNIFORM MONODISPERSE PARTICLES AND THEIR SHAPE-DIRECTED SELF-ASSEMBLY [patent_app_type] => utility [patent_app_number] => 16/396058 [patent_app_country] => US [patent_app_date] => 2019-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396058 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/396058
MORPHOLOGICALLY AND SIZE UNIFORM MONODISPERSE PARTICLES AND THEIR SHAPE-DIRECTED SELF-ASSEMBLY Apr 25, 2019 Abandoned
Array ( [id] => 14655747 [patent_doc_number] => 20190235002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors [patent_app_type] => utility [patent_app_number] => 16/381874 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4520 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381874 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/381874
Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors Apr 10, 2019 Abandoned
Array ( [id] => 18719272 [patent_doc_number] => 11796610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Compositions as molecular tags for hyperpolarization NMR and magnetic resonance and methods of making and using same [patent_app_type] => utility [patent_app_number] => 16/298621 [patent_app_country] => US [patent_app_date] => 2019-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 10459 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298621 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/298621
Compositions as molecular tags for hyperpolarization NMR and magnetic resonance and methods of making and using same Mar 10, 2019 Issued
Menu